Cytodyn Inc (CYDY)

[Saltz]

With so many catalysts lining up to drive the SP it would seem an organic uplist is fast approaching.

Obviously if the TNBC data mimics the results from the first two patients combined with the stream of incoming new patients, the granting of BTD and the basket approach will likely get the green light from the FDA.

I’m on pins and needles as to the possibility of the first two patients being outliers vs. the stronger possibility that they are the norm. The CCR5 evidence and MOA makes perfect sense as to the power of Leronlimab spurring Nader’s belief of 32 indications.

I can’t even venture to speculate the SP if we get the $40-50M non dilutive financing and accelerate the trials and the data continues to perform.

I’m a Murphy’s law guy who was raised by a lawyer. If something can go wrong it will. My gut says this is a case in point where we will be the exception to that rule from a macro perspective.

Seven plus years of investing and continual belief when the chips were down is/will be the sweetest of victories for our friends and fellow human beings that so desperately need this disrupting molecule.

This is shaping up to be a ride of a lifetime that was well worth the wait.